PACIRA BIOSCIENCES, INC. Deferred Tax Liabilities, Property, Plant and Equipment
PACIRA BIOSCIENCES, INC. (PCRX) had Deferred Tax Liabilities, Property, Plant and Equipment of $40.94 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-02-26
- 2025-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $40.94M.
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $34.37M.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $42.03M; Deferred Tax Liabilities, Property, Plant and Equipment as first filed $42.03M.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $54.74M.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment | Deferred Tax Liabilities, Property, Plant and Equipment as first filed |
|---|---|---|
| 2025-12-31 | $40.94M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $34.37M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $42.03M 10-K · filed 2025-02-27 | $42.03M 10-K · filed 2024-02-29 |
| 2022-12-31 | $54.74M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $81.42M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |